Second brazilian consensus on the management of crohn's disease in adults: a consensus of the brazilian organization for crohn's disease and colitis (gediib)
| dc.creator | Marcelloimbrizi | |
| dc.creator | Marjorie Costa Argollo | |
| dc.creator | Ligia Yukie Sassaki | |
| dc.creator | Rogerio Serafim Parra | |
| dc.creator | Abel Botelho Quaresma | |
| dc.creator | Andrea Vieira | |
| dc.creator | Adérson Omar Mourão Cintra Damião | |
| dc.creator | Antonio Carlos da Silva Moraes | |
| dc.creator | Cristina Flores | |
| dc.creator | Cyrla Zaltman | |
| dc.creator | Eduardo Garcia Vilela | |
| dc.creator | Júlio Pinheiro Baima | |
| dc.creator | Francisco Guilherme Cancela e Penna | |
| dc.creator | Bauru Universidade Nove de Julho | |
| dc.creator | Matheus Freitas Cardoso de Azevedo | |
| dc.creator | Adriana Ribas Andrade | |
| dc.creator | Natália Souza Freitas Queiroz | |
| dc.creator | Curitiba Hospital Santa Cruz | |
| dc.creator | Júlio Maria Fonseca Chebli | |
| dc.creator | Liliane Andrade Chebli | |
| dc.date.accessioned | 2025-07-03T22:06:39Z | |
| dc.date.accessioned | 2025-09-08T22:53:45Z | |
| dc.date.available | 2025-07-03T22:06:39Z | |
| dc.date.issued | 2022 | |
| dc.format.mimetype | ||
| dc.identifier.doi | https://doi.org/10.1590/S0004-2803.2022005S1-02 | |
| dc.identifier.issn | 16784219 | |
| dc.identifier.uri | https://hdl.handle.net/1843/83325 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Arquivos de Gastroenterologia | |
| dc.rights | Acesso Aberto | |
| dc.subject | Crohn Disease | |
| dc.subject | Adults | |
| dc.subject | Inflammatory Bowel Diseases | |
| dc.subject | Drug Therapy | |
| dc.subject | Disease Management | |
| dc.subject.other | Crohn Disease | |
| dc.subject.other | Adults | |
| dc.subject.other | Inflammatory Bowel Diseases | |
| dc.subject.other | Drug Therapy | |
| dc.subject.other | Disease Management | |
| dc.title | Second brazilian consensus on the management of crohn's disease in adults: a consensus of the brazilian organization for crohn's disease and colitis (gediib) | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 50 | |
| local.citation.spage | 20 | |
| local.citation.volume | 59 | |
| local.description.resumo | ABSTRACT – Background – Inflammatory bowel disease (IBD) is an immune-mediated disorder that includes Crohn’s disease (CD) and ulcerative colitis. CD is characterized by a transmural intestinal involvement from the mouth to the anus with recurrent and remitting symptoms that can lead to progressive bowel damage and disability over time. Objective – To guide the safest and effective medical treatments of adults with CD. Methods – This consensus was developed by stakeholders representing Brazilian gastroenterologists and colorectal surgeons (Brazilian Organization for Crohn's disease and Colitis (GEDIIB)). A systematic review of the most recent evidence was conducted to support the recommendations/statements. All included recommendations and statements were endorsed in a modified Delphi panel by the stakeholders and experts in IBD with an agreement of at least 80% or greater consensus rate. Results and conclusion – The medical recommendations (pharmacological and non-pharmacological interventions) were mapped according to the stage of treatment and severity of the disease in three domains: management and treatment (drug and surgical interventions), criteria for evaluating the effectiveness of medical treatment, and follow-up/patient monitoring after initial treatment. The consensus is targeted towards general practitioners, gastroenterologists, and surgeons interested in treating and managing adults with CD and supports the decision-making of health insurance companies, regulatory agencies, and health institutional leaders or administrators. | |
| local.publisher.country | Brasil | |
| local.publisher.department | MED - DEPARTAMENTO DE CLÍNICA MÉDICA | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://www.scielo.br/j/ag/a/HBTzdmQfG5fGSnHs8kRqzYy/?lang=en |